Nucleic acid extraction using organic solvents to remove inhibitors
US2015044698A1
Outer membrane protein 18 as a diagnostic marker for campylobacter
US2013302813A1
Cell wall protein CwpV (CD0514) as a diagnostic marker for Clostridium difficile ribotype 027
US2013052640A1
Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease
US2013130281A1
Cysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficile
EP2705154A1
Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
CN101111603A
Device and method for detection of analytes
WO2005020799A2
METHOD FOR MEASURING FCϵRII/CD23 IGE RECEPTOR IN HUMAN FECES AS AN INDICATOR OF A TH2 PREDOMINANT IMMUNE RESPONSE INVOLVED IN GASTROINTESTINAL ILLNESSES
HK1058704A1
Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrin as a marker
EP1554580A2
Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel
WO2004022713A2
Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
US6872540B2
Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
CA2427898A1
Method for differentiating between irritable bowel syndrome and inflammatory bowel disease using lactoferrin as marker
AU4973200A
Recombinant toxin A/toxin B vaccine against Clostridium Difficile
CA2365914A1
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
US6733760B1
Recombinant toxin A/toxin B vaccine against Clostridium difficile
